CardioGenics Holdings (CardioGenics Holdings) Total Payout Ratio : 0.01 (As of Jun. 15, 2024)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

CardioGenics Holdings's current Total Payout Ratio is 0.01.

CardioGenics Holdings Total Payout Ratio Historical Data

The historical data trend for CardioGenics Holdings's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Total Payout Ratio Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Total Payout Ratio

Get a 7-Day Free Trial

0.06

0.20

0.03

0.02

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	0.06

Competitive Comparison of CardioGenics Holdings's Total Payout Ratio

For the Diagnostics & Research subindustry, CardioGenics Holdings's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Total Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Total Payout Ratio falls into.

CardioGenics Holdings Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

CardioGenics Holdings's Total Payout Ratio for the fiscal year that ended in Oct. 2015 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0.04	+	0)	/	-1.916
	=	0.02

CardioGenics Holdings's Total Payout Ratio for the quarter that ended in Jan. 2016 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0.007	+	0)	/	-0.125
	=	0.06

CardioGenics Holdings Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines